Patients <40 years at diagnosis had a worse prognosis, but this effect was only marginally statistically significant and not seen when different cutoffs for age (50, 60) were used.
← all excerpts
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
1
—
—